Canaccord raised the firm’s price target on Staar Surgical (STAA) to $28 from $20 and keeps a Hold rating on the shares. The firm raised its target after Alcon (ALC) will purchase all outstanding shares of Staar for $28/share, giving them a $1.5B total enterprise value.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA: